-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Neutral on Tandem Diabetes Care, Raises Price Target to $21

Benzinga·12/17/2025 13:10:07
语音播报
Mizuho analyst Anthony Petrone maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and raises the price target from $18 to $21.